Holzer Holzer & Fistel, LLC is Investigating Potential Violations of Federal Securities Laws by Cell Therapeutics, Inc.

Holzer Holzer & Fistel, LLC is investigating potential violations of the federal securities laws by Cell Therapeutics, Inc. (“Cell Therapeutics” or the “Company”) (NASDAQ: CTIC). The investigation focuses on whether a series of statements regarding Cell Therapeutics’ business, its prospects and its operations were materially false and misleading at the time they were made.

If you invested in Cell Therapeutics common stock between May 5, 2009 and February 8, 2010 and have questions concerning your legal rights, you are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at 888-508-6832.

Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.

CTI BioPharma (NASDAQ:CTIC)
Historical Stock Chart
From Feb 2025 to Mar 2025